BioDlink International Company Limited (1875.HK) HKSE

Currency In HKD

AD

BioDlink International Company Limited

Address

No. 120 Changyang Street

Suzhou, JS 215024

China

Phone

86 512 6296 5186

Sector

Healthcare

Industry

Biotechnology

Employees

611

First IPO Date

November 08, 2019

Key Executives

NameTitlePayYear Born
Jincai LiExecutive Chairperson of the Board01973
Yuan FangJoint Company Secretary0N/A
Li YinChief Technology Officer01966
Wing Yat LuiJoint Company Secretary01990
Yifan ChenJoint Company Secretary01980
Ben XiaoGroup Vice President of Finance & Investor Relations01982
Jian Bo ZhangChief Operating Officer01978
AD

Description

BioDlink International Co., Ltd. operates as a clinical-stage biopharmaceutical firm, dedicating its resources to the development and future commercialization of novel oncology drugs and therapeutic solutions. Its pipeline features several key product candidates, including TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009, and its primary base of operations is situated in Suzhou, China.

AD